An estrogen-like drug, raloxifene, has no demonstrated benefit on memory and thinking skills for women with dementia due to Alzheimer's disease, according to a study published in the November 4, 2015, ...
When the Food and Drug Administration announced that the agency would be removing the black-box warning from hormone ...
Health and Human Services Secretary Robert F. Kennedy Jr. announced Monday that the U.S. Food and Drug Administration would remove “broad black box” warnings from hormone replacement therapy products ...
Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food and Drug ...
The U.S. Food and Drug Administration (FDA) announced this week that it would no longer require "black box warnings"-the highest level of medication safety warnings-on prescription low-dose estrogen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results